Trastuzumab
CAS: 180288-69-1
Ref. TM-T9912
| 1mg | 152.00 € | ||
| 5mg | 511.00 € | ||
| 10mg | 640.00 € | ||
| 25mg | 1,009.00 € | ||
| 50mg | 1,364.00 € | ||
| 100mg | 1,831.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Product Information
Name:
Trastuzumab
Synonyms:
- Trastuzumab (anti-HER2)
- anti-HER2
- Herceptin
- Trastuzumab [USAN:INN]
- Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2gamma1-chain antihuman p185(sup c-erbB2) receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
- Unii-P188Anx8Ck
- Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
Description:
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
Approximately 145.53 kDa
Purity:
98% - 99.50%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T9912 Trastuzumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
